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Summary Under certain circumstances sequence-specific inhibition of gene expression may be achieved in
intact cells using exogenous anti-sense oligodeoxynucleotides. The efficacy of this approach to investigating
gene function is limited in part by the rapid serum nuclease mediated degradation of oligodeoxynucleotides in
culture media. In order to determine the relative contributions of 3'-exonuclease, 5'-exonuclease and
endonuclease activity in fetal calf serum to oligodeoxynucleotide destruction, we have tested chimeric N-ras
anti-sense sequence molecules protected against exonuclease attack with terminal methylphosphonate diester
linkages. An 18-mer with two methylphosphonate diester linkages at the 3'-terminus, a 20-mer with two
methylphosphonate diester groups at both ends, and the 16-mer 3'-methylphosphonate monoester components
of their respective piperidine hydrolysates were totally resistant to venom phosphodiesterase, whereas the 16-
mer 3'-hydroxyl components of the hydrolysates were rapidly degraded. Both the chimeric
oligodeoxynucleotides and 3'-methylphosphonate monoesters were considerably more stable than normal 3'-
hydroxyl oligodeoxynucleotides at 37'C in McCoy's 5A medium containing 15% heat inactivated fetal calf
serum. Typically 20-30% of the former (initial concentration 10-100 jM) remained intact at 20 h as compared
to the latter which were 88-100% degraded in 4 h and undetectable at 20 h. We conclude that a 3'-
phosphodiesterase activity is a predominant nuclease responsible for oligodeoxynucleotide degradation by
fetal calf serum, and that for cell culture studies, significant protection of oligodeoxynucleotides may be
achieved by incorporating 3'-terminal methylphosphonate diester or even monoester end groups.
Short synthetic anti-sense oligodeoxynucleotides with normal
phosphodiester linkages have been reported to inhibit
targeted gene expression when applied exogenously to intact
cells in tissue culture (Zamecnik & Stephenson, 1978;
Zamecnik et al., 1986; Wickstrom et al., 1986; Heikkila et
al., 1987; Harel-Bellan et al., 1988; Holt et al., 1988;
Wickstrom et al., 1988). However, the efficacy and general
applicability of this approach to investigating oncogene or
anti-oncogene function may be limited, in part, by the
generally rapid serum nuclease mediated degradation of
oligodeoxynucleotides in culture media. In contrast to our
own experience, Wickstrom (1986) reported that a c-Ha-ras
anti-sense 15-mer oligodeoxynucleotide was not detectably
broken down in medium containing 5% fetal calf serum
when incubated at 37°C for 2h. However, a c-myc anti-sense
15-mer, which inhibited c-myc protein synthesis in intact
HL-60 cells, underwent significant loss within 1 h in the
culture supernatant containing 10% fetal calf serum and had
virtually disappeared by 8 h (Wickstrom et al., 1988). Others
working on anti-sense oligodeoxynucleotide-induced
inhibition of c-myc protein synthesis have carefully selected
batches of fetal calf serum for low levels of nuclease activity
at the outset by testing the degradation of 32P-labelled
oligonucleotide (Harel-Bellan et al., 1988; Holt et al., 1988).
Breakdown of c-myc sense and anti-sense 15-mers in media
containing such selected serum was still appreciable and Holt
et al. (1988) concluded that this occurred predominantly
through exonuclease attack. It was not possible to determine
from their data the actual relative contributions of 3'-
phosphodiesterase, 5'-phosphodiesterase and endonuclease
activities, although the latter appeared to be insignificant.
Zamecnik and co-workers have previously used
oligodeoxynucleotides terminally blocked with isourea
groups and with 3'-deoxythymidine on the assumption that
these would be less susceptible to exonucleolytic enzymes
present in the serum-containing incubation medium and
within the cells (Zamecnik & Stephenson, 1978; Zamecnik et
al., 1986). However, the extent to which such modifications
protected the oligodeoxynucleotides against degradation was
not determined and, in the light of the variability in results
obtained with HIV infected cells, these authors suggested
that more work needed to be done with end-blocked
oligonucleotides.
In the present work we have determined the relative extent
to which 3'phosphodiesterase, 5'-phosphodiesterase and
endonucleases present in fetal calf serum contribute to
breakdown of oligodeoxynucleotides by using preparations
of an N-ras anti-sense sequence (Figure 1) blocked at both
the 5' and 3' ends or just the 3' terminus with two
methylphosphonate diester linkages (Smith et al., 1986). In
addition, piperidine catalysed hydrolysis of the parent
chimeric molecules (Miller et al., 1983; Murakami et al.,
1985) provided a convenient source of oligodeoxynucleotides
with which to evaluate the protective effects of
methylphosphonate monoester end groups (Figure 1). Our
results suggest that a 3'-phosphodiesterase activity
(oligonucleate 5'-nucleotidohydrolase) plays a predominant
role in the breakdown of oligodeoxynucleotides by fetal calf
serum and that significant increases in the half lives of intact
molecules in tissue culture medium can be achieved by
merely protecting the 3' ends with methylphosphonate
diester or even monoester groups.
Materials and methods
Synthesis of oligodeoxynucleotides
Methylphosphonodiester/phosphodiester chimeric oligo-
deoxynucleotides were very kindly assembled for us on an
automatic DNA synthesiser by Stephen Bates of Applied
Biosystems, Warrington, Cheshire, and were also synthesised
in our own laboratory on an Applied Biosystems 381A
Synthesizer, using a combination of methylphosphona-
midite and f3-cyanoethyl phosphoramidite chemistries,
developed from the original work of Dorman et al. (1984).
The oligonucleotides, in the fully protected, trityl-on,
controlled pore glass support-bound form, were deprotected
following the procedure for methylphosphonate oligo-
nucleotide analogues (Maher & Dolnick, 1988). The
products, carrying 5'-dimethoxytrityl groups as the sole
remaining protecting functions, were dissolved in 5 ml 0.1 M
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Human N-ras gene sequence
met thr glu tyr lys leu val ....
5' .... A-T-G-A-C-T-G-A-G-T-A-C-A-A-A-C-T-G-G-T-G.... 3'
Codon
no. 1 2 3 4 5 6 7
N-ras anti-sense chimeric oligodeoxynucleotides
3' .. ..T/A/C-T-G-A-C-T-C-A-T-G-T-T-T-G-A-C ....5'
3'....T/A/C-T-G-A-C-T-C-A-T-G-T-T-T-G-A-C/C/A.... 5'
5'-(P) (M) -3'
15 2
5'-(M) (P) (M) -3'
2 15 2
Components of 1M piperidine hydrolyzate of 5'-(P) (M) -3' 18-mer
15 2
3' ....C-T-G-A-C-T-C-A-T-G-T-T-T-G-A-C .... 5
3 '.../C-T-G-A-C-T-C-A-T-G-T-T-T-G-A-C ....5 '
5'-OH,3'-OH (P)
15
5'-OH,3'-M (P)
15
Componerits of 1M piperidine hydrolyzate of 5'-(M) (P (M) -3' 20-mer
2 15 2
3'... .C-T-G-A-C-T-C-A-T-G-T-T-T-G-A-C .... 5
3' .../C-T-G-A-C-T-C-A-T-G-T-T-T-G-A-C .... 5
'
3', . ..C-T-G-A-C-T-C-A-T-G-T-T-T-G-A-C/. .. 5'
3' . . ./C-T-G-A-C-T-C-A-T-G-T-T-T-G-A-C/ ... 5'
5'-OH,3'-OH (P)
15
5'-OH,31-M (P)
15
5'-M,3'-OH (P)
15
5'-M,3'-M (P)
15
Figure 1 Structures of N-ras anti-sense methylphosphonodiester/phosphodiester chimeric oligodeoxynucleotides and their
piperidine hydrolysis products. In the sequence representations, an internal / symbolises a methylphosphonate diester linkage and a
terminal / signifies a methylphosphonate monoester group; an internal - represents a phosphodiester linkage. In the text the
structures are referred to by a shorthand notation where P in parentheses with a subscript numeral represents the number of
consecutive phosphodiester linkages, M in parentheses with a subscript numeral represents the number of consecutive
methylphosphonate diester linkages, -OH represents a terminal hydroxyl, and -M a terminal methylphosphonate monoester group.
triethylammonium acetate, pH 7, containing 0.2% pyridine,
to prevent premature detritylation, and were purified on C-
18 Sep Pak cartridges (Waters Chromatography Division,
Millipore (UK) Ltd). The cartridges were washed with 6ml
0.2% pyridine/0. 1 M triethylammonium acetate, pH 7,
followed by 17 ml 15% acetonitrile/0.2% pyridine/0.1 M
triethylammonium acetate, pH 7, to elute failure sequences.
The dimethoxytrityl group was removed in situ with 10ml
0.5% trifluoroacetic acid/water applied over a 15 min period,
and the' cartridges were washed with 10ml 0.1 M triethyl-
ammonium acetate, pH 7, followed by 10 ml water. The
products were eluted from the cartridges with 2 ml 30%
acetonitrile/water and dried in a Savant Instrutnents Speed
Vac Concentrator (Stratech Scientific Ltd). The oligo-
nucleotide preparations were analysed by strong anion
exchange hplc on a Partisil-10 SAX column (Whatman Ltd),
temperature 45°C, 60min gradient, 0.001-0.3 M potassium
phosphate in 60% formamide/water, pH 6.8, 2 mlmin-1
(Sproat & Gait, 1984), and were shown to contain only
minor quantities of failure sequences of shorter retention
times than the single major peaks (see Figure 3). The
oligonucleotides were deemed to be sufficiently pure for the
present experiments and were used without further
purification.
Phosphodiester oligodeoxyribonucleotides (trityl-on) were
synthesised on an Applied Biosystems Model 381A DNA
Synthesizer and were deprotected in concentrated ammonia
solution for 8 h at 60°C. Following deprotection the
oligodeoxynucleotides were purified on C-18 Sep Pak
cartridges by the same procedure as that described for the
chimeric oligodeoxynucleotides. The products were analysed
by SAX hplc, and reverse phase hplc on Partisil-O0 ODS-3
(Whatman Ltd) and Aquapore RP-300 (Applied Biosystems
Ltd) columns using a 30min gradient from 0 to 30%
acetonitrile in 0.1 M triethylammonium acetate, pH 7, at a
flow rate of 1.5mlmin-1. No impurities were detected in
these preparations. The N-ras anti-sense phosphodiester
oligodeoxyribonucleotide 16-mer, corresponding to the phos-
phodiester portion of the chimeric oligodeoxynucleotides
(Figure 1), and carrying a 3'-terminal phosphate monoester
group, was synthesised via an intermediate 17-mer with a 3'-
terminal ribonucleoside, uridine, using a uridine-derivatised
controlled pore glass support (Peninsula Laboratories
Europe Ltd). The uridine was subsequently removed by
periodate oxidation and fl-elimination to yield the
oligodeoxyribonucleotide 3'-phosphate derivative (Keith &
Gilham, 1974).
Piperidine catalysed hydrolysis of chimeric
oligodeoxynucleotides
Chimeric oligodeoxynucleotides were incubated at 37°C in
1 M solutions of piperidine. At the end of the incubation
periods the piperidine was either neutralised with an
equivalent amount of 6N hydrochloric acid or removed by
evaporation in a Speed Vac concentrator, followed by co-
evaporation twice with water to eliminate trace residues of
the base. Hydrolysed samples were analysed by SAX hplc,
and by reverse phase hplc on an Aquapore RP-300 column
using a 20min gradient of 5-50% acetonitrile/0. 1 M triethyl-
ammonium acetate, pH 7, at a flow rate of 2mlmin-1.
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Enzyme digestion and determination of culture medium
stability of oligodeoxynucleotides
Chimeric oligodeoxynucleotides and their piperidine
hydrolysates were incubated at 7.5yM concentrations with
0.02 units of phosphodiesterase 1 from Crotalus adamanteus
venom (Sigma Chemical Co Ltd) at 37°C in 454MuI of 50mM
Tris HCI, 10mM magnesium chloride, pH 8.0, with or
without the further addition of 70 units of bovine intestinal
alkaline phosphatase (Sigma Chemical Co Ltd). Samples
(140pl) of the incubation mixtures were removed at various
times, mixed with 20M1 200mM EDTA and 69pl acetonitrile,
and applied to C-18 Sep Pak cartridges. The cartridges were
washed with 1 ml 30% acetonitrile/water and the combined
effluents were dried in a Speed Vac concentrator before
analysis by reverse phase hplc on a Aquapore RP-300
column.
Oligodeoxynucleotides were incubated in McCoy's 5A
tissue culture medium (GIBCO Ltd) containing 15% heat
inactivated (50°C, 30min) fetal calf serum (Biological
Industries Ltd) at 370C in the presence or absence of
exponentially proliferating HT29/5 cells. At various times
lOO1p samples were removed, mixed with 10up1 200mM
EDTA and 1 ml 0.1 M triethylammonium acetate, pH 7, and
applied to C-18 Sep Pak cartridges. The cartridges were
washed with 10ml 0.1M triethylammonium acetate, pH 7,
5ml 5% acetonitrile in the same buffer and 10ml water.
Oligonucleotides were eluted with 1.2ml 30% acetonitrile in
water and concentrated in a Speed Vac concentrator before
analysis by SAX hplc.
Results
Syntheses of the c-myc 15-mer oligodeoxynucleotides
described by Wickstrom et al. (1986, 1988) and others
(Heikkila et al., 1987; Holt et al., 1988; Harel-Bellan et al.,
1988) were repeated as part of a project to determine the
general applicability of the reported anti-sense approach to
inhibiting myc gene expression in intact cells. Figure 2a
depicts the reverse phase hplc separation of the purified myc
anti-sense 15-mer sequence, 5'-AACGTTGAGGGGCAT-3',
from deoxyribonucleoside and deoxyribonucleotide standards
dissolved in McCoy's 5A medium containing 15% fetal calf
serum, immediately after mixing. The chromatogram in
Figure 2b represents the analysis of the oligonucleotide by
strong anion exchange, Partisil-10 SAX hplc. The same
oligonucleotide was dissolved alone in the tissue culture
medium and maintained at 20°C for 2h before analysTs by
reverse phase hplc (Figure 2c). It can be seen that, even at
room temperature, considerable degradation had occurred
during this period. Reverse phase hplc analysis of oligo-
nucleotides is less informative than strong anion exchange
chromatography and therefore the column effluent
containing the oligonucleotides (between the vertical arrows
in Figure 2c) was collected and re-analysed on the SAX
column (Figure 2d). A ladder of oligonucleotide degradation
products was apparent, differing by the successive removal
of a single nucleotide unit and decreasing in abundance with
decreasing chain length. Such a pattern implicated a
predominantly exonucleolytic attack by serum nucleases, and
it seemed likely that a major factor in this would be the 3'-
phosphodiesterase activity we had previously encountered in
our work on nucleotide prodrugs (Tidd et al., 1982). In
order to determine the relative contributions of
endonuclease, 3'-phosphodiesterase and 5'-phosphodiesterase
activities to degradation of oligodeoxynucleotides by fetal
calf serum we tested oligonucleotides protected from
exonuclease attack by two consecutive terminal methyl-
phosphonate diester linkages. This configuration made
allowance for the observation that although the non-ionic
methylphosphonate linkage itself is resistant to nuclease
hydrolysis, venom phosphodiesterase can bypass one
terminal phosphonate linkage and cleave the phosphodiester
bond two base residues removed from the 3'-OH terminus
(Miller et al., 1980), whereas phosphodiester oligodeoxy-
nucleotides with two methylphosphonate linkages at each
end are resistant to degradation by purified exonucleases
(Agrawal & Goodchild, 1987). Two chimeric oligodeoxy-
nucleotides representing an N-ras anti-sense sequence were
used (Figure 1). One, (P)15(M)2, an 18-mer with two methyl-
phosphonate linkages at the 3' end only, was designed to
resist 3'-phosphodiesterase attack while permitting
degradation by 5'-phosphodiesterase and endonuclease. The
other, (M)2(P)15(M)2, a 20-mer with two methylphosphonate
linkages at both ends of the molecule, permitted an
evaluation of the contribution of endonuclease mediated
breakdown. The core phosphodiester 16-mer sequence was
the same in both oligodeoxynucleotides.
Methylphosphonate diesters are susceptible to random base
catalysed hydrolysis of one of the ester linkages under con-
ditions in which phosphodiesters are unaffected (Murakami
et al., 1985; Miller et al., 1983). Consequently, it was
possible to characterise the chimeric oligodeoxynucleotides
by following the course of 1 M piperidine catalysed hydroly-
sis at 37°C using SAX hplc to analyse the reaction mixtures
(Figures 1 and 3). Partial hydrolysates (1 h) of (P)15(M)2
contained five different components including the starting
material as predicted for random cleavage at methyl-
phosphonate diester linkages. Hydrolysis was complete at
20.5 h when two piperidine-resistant species remained in
roughly equal amounts, corresponding to the core phospho-
diester 16-mer with either a 3'-hydroxyl (5'-OH,3'-OH) or a
3'-methylphosphonate monoester (5'-OH,3'-M) terminus.
The latter, being more highly charged, was retained longer
on the anion exchange column (Figure 3). The situation was
somewhat more complex in the case of (M)2(P)15(M)2, there
being 21 possible different components including the starting
material which could be present in partial hydrolysis mix-
tLires. Four piperidine resistant species remained in roughly
similar amounts at 20.5 h corresponding to the core
phosphodiester 16-mer with 0, 1 or 2 terminal methyl-
phosphonate monoester groups. The SAX column did not
b
d
36 40 44 48
Retention time (min)
Figure 2 Stability of c-myc anti-sense phosphodiester 15-mer
oligodeoxynucleotide at 20°C in McCoy's 5A tissue culture
medium containing 15% fetal calf serum. a, Reverse phase hplc
separation on an Aquapore RP-300 column of the oligo-
nucleotide, deoxynucleoside and deoxynucleotide standards in
culture medium, immediately after mixing. b, SAX hplc analysis
of the 15-mer preparation. c, Reverse phase hplc analysis on an
ODS-3 column of a 15-mer solution in culture medium following
incubation for 2h at 20°C. The oligonucleotides eluting between
the vertical arrows were collected and reanalysed (d) by SAX
hplc.
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Figure 3 Piperidine (1 M) catalysed hydrolysis (37°C) of N-ras
anti-sense chimeric oligodeoxynucleotides with terminal methyl-
phosphonodiester linkages. SAX hplc analysis. The abbreviations
used are explained in Figure 1.
0 h
1 h
3 h
separate the two isomers, 5'-M,3'-OH and 5'-OH,3'-M, with
single methylphosphonate monoester groups at either the 5'
or the 3' ends of the molecules, and consequently the area of
their peak was approximately twice the individual areas of
the peaks of the other two components. The product with
methylphosphonate monoester groups at both ends of the
molecule, 5'-M,3'-M, had the highest negative charge and
was retained the longest by the column (Figure 3). Analysis
of the same samples by reverse phase hplc was considerably
quicker but less informative since resolution of the various
piperidine-resistant 16-mer products was not achieved.
Reverse phase hplc was adequate to monitor gross degra-
dation of oligonucleotides (Figure 2) and therefore was used
to determirle the effects of venom phosphodiesterase on the
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Figure 4 Venom phosphodiesterase digestion of the mixture of
oligodeoxynucleotide 16-mers (see Figure 3) formed by piperidine
hydrolysis of the N-ras anti-sense (M)2(P)1i(M)2 chimeric 20-mer.
The Aquapore RP-300 reverse phase hplc analysis shown did not
separate the four oligodeoxynucleotides differing by the presence
of hydroxyl or methylphosphonate monoester groups at their 3'
and 5' termini. The phosphodiesterase-resistant 7.69min peak
from the 3 h sample was collected and reanalysis by strong anion
exchange hplc demonstrated the presence of two components
with 3'-terminal methylphosphonate monoester groups (see Table
I). Quantitative results are presented in Figure 5.
Time (h)
Figure 5 a, Venom phosphodiesterase digestion of N-ras anti-
sense chimeric oligodeoxynucleotides (O, A, 7.5gM) and their
piperidine (1 M, 37°C, 21 h) hydrolysis products (0, A, 7.5 jiM).
Reverse phase hplc analysis on an Aquapore RP-300 column. b,
Venom phosphodiesterase + alkaline phosphatase digestion of
piperidine hydrolysates. (P)15 3'-P, N-ras anti-sense phospho-
diester 16-mer 3'-phosphate monoester oligodeoxynucleotide,
with the same base sequence as the products of piperidine
hydrolysis, used as a control for alkaline phosphatase activity,
incubated with one-hundredth the amount of alkaline phospha-
tase present in the piperidine hydrolysate digestions, analysed for
dephosphorylation by SAX hplc. See Table I for SAX hplc
identification of-phosphodiesterase-resistant components of piper-
idine hydrolysates in a.
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chimeric oligodeoxynucleotides and their piperidine hydroly-
sis products (Figures 4 and 5a). Both chimeric oligodeoxy-
nucleotides were resistant to digestion by the 3'-phospho-
diesterase, whereas the piperidine hydrolysates were rapidly
degraded to approximately half the initial oligonucleotide
concentration within 1 h and were then resistant to further
hydrolysis (Figure Sa). The venom phosphodiesterase resist-
ant components of the piperidine hydrolysates were collected
in the reverse phase hplc effluent and re-analysed by SAX
hplc, when they were shown to be those oligodeoxy-
nucleotides with a 3'-methylphosphonate monoester group
(Table I). This underlined the requirement of venom
phosphodiesterase for a free 3'-OH group. Digestion of the
piperidine hydrolysates was repeated in the presence of a
large excess (70 units in 457 1, total volume) of alkaline
phosphatase (Figure Sb). In this case the oligodeoxy-
nucleotide 3'-methylphosphonate monoesters were slowly
degraded as evidenced by the gradual reduction in oligo-
nucleotide concentration beyond the 1 h time point. In
contrast, the N-ras anti-sense phosphodiester 16-mer 3'-
phosphate control, (P)153'-P was dephosphorylated so
rapidly that this reaction, monitored by strong anion
exchange hplc, was complete within the time taken to
remove the 0 h sample after addition of only one-hundredth
of the amount of alkaline phosphatase used in the piperidine
hydrolysate digestions. Therefore, it was apparent that the
methylphosphonate monoesters were only poor substrates
for alkaline phosphatase.
The stability of the chimeric oligodeoxynucleotides at 37°C
in McCoy's 5A medium containing 15% heat inactivated
fetal calf serum was determined by SAX hplc analysis and
compared with the persistence, intact, of normal phospho-
diester oligodeoxynucleotides under the same conditions. The
results of Figure 6 exemplify the type of data obtained in
these experiments. The top section shows what appears to be
the predominantly exonucleolytic degradation of the N-ras
anti-sense all-phosphodiester 20-mer with the same base
sequence as the chimeric 20-mer (Figure 1). It is apparent
that all the starting material had disappeared within 2 h. The
lower section presents the data obtained with the corre-
sponding exonuclease-resistant chimeric N-ras anti-sense 20-
mer, (M)2(P)15(M)2. Here the first step in degradation of the
oligonucleotide occurred, of necessity, by endonucleolytic
attack alone and a fairly even distribution of shorter chain
lengths was produced. Forty-four per cent of the original
oligonucleotide was still present at 4 h. The quantitative
results of this experiment are presented in Figure 7a. Neither
of the all-phosphodiester oligodeoxynucleotides remained
intact at 4h. In contrast, the chimeric oligodeoxynucleotides,
(M)2(P)15(M)2 and (P)1 (M)2 were still detectable at 22h at
17% and 30% of their initial concentrations respectively.
Surprisingly, (P)1 5(M)2 was less readily degraded than
(M)2(P)15(M)2 with 73% of the molecules surviving intact at
4h. The results of a similar experiment based upon myc
sequences are presented in Figure 7b. The myc anti-sense
phosphodiester 15-mer was the sequence previously referred
to in Figure 2 which has been reported to inhibit myc gene
expression in intact cells (Wickstrom et al., 1986, 1988;
Heikkila et al., 1987; Holt et al., 1988; Harel-Bellan et al.,
1988) and the myc sense phosphodiester 15-mer was its
complement, 5'-ATGCCCCTCAACGTT-3', used by Heik-
kila et al. (1987) as a control in their experiments. Approxi-
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Figure 6 Stability of oligodeoxynucleotides at 37°C in McCoy's
5A medium containing 15% heat inactivated fetal calf serum.
Representative SAX hplc analyses obtained with phosphodiester
and methylphosphonodiester/phosphodiester chimeric oligode-
oxynucleotides.
Table I Identification of venom phosphodiesterase-resistant components in IM piperidine hydrolysates (21 h, 37°C) of N-ras anti-sense
methylphosphonodiester/phosphodiester chimeric oligodeoxynucleotides
SAX hplc analysis peak retention times (min)
Peak 2 Approximate ratio
Peak I 5'-M,3'-OH 16-mer Peak 3 of areas of
Sample 5'-OH,3'-OH 16-mer and/or 5'-OH,3'-M 16-mer 5'-M,3'-M 16-mer peaks 1:2:3
(A) Piperidine hydrolysates 43.0 45.6 1:1:0
of 5'-(P)15(M)2-3' 18-mer
(B) Venom phosphodiesterase - 45.5 0:1:0
digest of (A)
(A)+(B) combined 43.0 45.6 - 1:2:0
(C) Piperidine hydrolysate 43.0 45.6 48.1 1:2:1
of 5'4M)2(P)15(M)2-3'
20-mer
(D) Venom phosphodiesterase - 46.2 48.9 0:1:1
digest of (C)
(C)+(D) combined 43.5 46.3 48.9 1:3:2348 D.M. TIDD & H.M. WARENIUS
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Figure 7 Persistence of intact phosphodiester and
methylphosphonodiester/phosphodiester chimeric oligodeoxy-
nucleotides at 37°C in McCoy's 5A medium containing 15% heat
inactivated fetal calf serum. SAX hplc analyses.
mately 3% of the myc phosphodiester sense oligodeoxy-
nucleotide remained intact at 4h, whereas the
phosphodiester anti-sense sequence appeared to be somewhat
more resistant to degradation with 12% remaining at this
time (Figure 7b). The lower rate of degradation of the myc
anti-sense 15-mer may be related to the presence of the six
guanine residues and the tendency of the molecules to self-
associate in solution (data not shown). The same result was
obtained in a separate experiment (data not shown) and is
mirrored in the differential sensitivity of the chimeric myc
oligodeoxynucleotides (Figure 7b). Neither of the phospho-
diester 15-mers remained intact at 22 h whereas
(M)3(P)8(M)3 chimeric molecules incorporating the same
sequences, with three consecutive methylphosphonate lin-
kages at each end, exhibited considerable resistance to
degradation (Figure 7b). The chimeric myc nonsense
oligodeoxynucleotide, 5'-GTACGGTAACGGGAT-3' was a
random permutation of the bases present in the anti-sense
5'-OH, 3'-M 16-mer
5'-OH, 3'-M
+ 5'-M, 3-OH 16-mers
23%
51%
Time (h)
Figure 8 Persistence of intact N-ras anti-sense phosphodiester
oligodeoxynucleotides at 37°C in McCoy's 5A medium
containing 15% heat inactivated fetal calf serum. The oligodeoxy-
nucleotides were produced by piperidine hydrolysis of chimeric
molecules and were present as the mixtures indicated in Figure 1.
SAX hplc analysis was used to follow degradation of individual
components of the mixtures differing only in the presence or
absence of terminal methylphosphonate monoester groups.
Percentage survivals of intact molecules at 46h are indicated on
the figure. a, Piperidine hydrolysate (1 M, 37°C, 22 h) of
5'4P)15(M)2-3' 18-mer; b, piperidine hydrolysate (1 M, 37°C, 22h)
of 5'4M)2(P)15(M)2-3' 20-mer.
sequence. The starting oligodeoxynucleotide concentrations
were 10Mm in the experiment of Figure 7. We observed
similar percentage survivals of intact chimeric oligodeoxy-
nucleotides in culture medium in a separate experiment in
which the starting concentrations were 100yM (data not
shown). In that experiment the concentrations of intact N-
ras anti-sense (P)M5(M)2 and (M)2(P)V5(M)2 at 19.5 h were
30.0Mm and 26.6pM respectively. In a further experiment,
the degradation of lOpM chimeric oligodeoxynucleotides in
culture medium alone was compared with that in exponen-
tially proliferating cultures of HT29/5 cells. Samples of
media were analysed by reverse phase hplc and no detectable
differences in the rates of breakdown of the oligonucleotides
were observed between incubations in the presence and
absence of living cells over a period of 48 h (data not
shown).
As a further control for these experiments we measured
the persistence in culture medium of the components pro-
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duced by piperidine hydrolysis of the chimeric oligodeoxy-
nucleotides. The results are presented in Figure 8. The core
phosphodiester 16-mer with terminal hydroxyl groups at
each end, 5'-OH,3'-OH, was rapidly degraded to 5% of its
initial concentration within 5 h and was undetectable at 22 h
(Figure 8a). In contrast, it is evident that even the presence
of a 3'-terminal methylphosphonate monoester group is
sufficient to afford significant protection against degrada-
tion. In the case of 5'-OH,3'-M, 29% of the initial concent-
ration of the oligonucleotide remained at 46h (Figure 8a),
while 51% of 5'-M,3'-M was still present at this time (Figure
8b). It would appear that the endonuclease activity of the
fetal calf serum decayed during the initial 22 h of the
incubation since essentially no further reduction in the
concentration of intact 3'-methylphosphonate oligo-
nucleotides occurred between 22 and 46 h.
Discussion
The present investigation was primarily designed to deter-
mine the potential for protecting anti-sense oligodeoxy-
nucleotides against breakdown by serum nucleases in tissue
culture media. Consequently, we set out to demonstrate the
relative contributions of 5'-phosphodiesterase, 3'-phospho-
diesterase and endonuclease present in fetal calf serum to
such breakdown. In order to achieve this we have measured
the degradation of oligodeoxynucleotides blocked against
exonucleolytic attack at the 3'-terminus, and both the 3'- and
S'-ends of the molecules with two consecutive methyl-
phosphonate diester linkages. Obviously, the .absolute
concentrations of nucleases will vary from batch to batch of
serum and, therefore, the data can only be taken to give a
general idea of the relative activities which are likely to be
encountered.
It is evident from the data (Figure 7) obtained with
(M)2(P)1 (M)2 that, contrary to the conclusions of Holt et
al. (1988), breakdown of oligodeoxynucleotides by serum
endonucleases is by no means insignificant, but that under
normal circumstances the contribution of endonuclease
attack may be masked by a predominant exonucleolytic
mechanism of degradation. However, 5'-phosphodiesterase
would appear not to be significant since (P)15(M)2 was even
less readily degraded than (M)2(P)15(M)2 (Figure 7). Presu-
mably, the two chimeric oligodeoxynucleotides adopted
different conformations in solution which made
(M)2(P)15(M)2 a better substrate for the endonucleases than
(P)15(M)2. The considerable degree of protection afforded by
3'-methylphosphonate linkages would suggest that 3'-
phosphodiesterase, or more correctly oligonucleate 5'-
nucleotidohydrolase, is the major enzyme activity of fetal
calf serum responsible for oligodeoxynucleotide breakdown.
The data of Figure Sb demonstrate that methylphosphonate
monoesters are poor substrates for alkaline phosphatase, an
observation which may be relevant to the finding that this
group alone, when present on the 3'-terminus of a phospho-
diester oligodeoxynucleotide, provided essentially the same
degree of protection as two consecutive 3'-terminal methyl-
phosphonate diester linkages (Figures 7 and 8). Terminal
methylphosphonate linkages were also shown to endow
considerable protection to myc sequence oligodeoxy-
nucleotides (Figure 7). Such modifications could conceivably
enhance the activity of the anti-sense molecule in cell systems
where it has been shown to inhibit myc gene expression.
It is noteworthy that the concentrations of chimeric
oligodeoxynucleotides were apparently not saturating for the
serum endonucleases since approximately the same percent-
age degradation was observed at 10pM and 100pM. Also,
the enzyme activities appeared to decay during the first 22 h
of incubation at 37°C (Figure 8); this observation might be
exploited in the design of cell culture experiments with anti-
sense oligonucleotides since in cultures of exponentially
proliferating HT29/5 cells, at least, extracellular degradation
of the oligonucleotides was mediated entirely by the serum
component of the culture media without any detectable
contribution from the cells.
The overall conclusion from our results is that any
irreversible blockage of the 3'-end of an oligodeoxy-
nucleotide would suffice to enhance the lifetime of the
molecule in the presence of fetal calf serum. However, we are
presently continuing our work with chimeric
methylphosphonodiester/phosphodiester oligodeoxy-
nucleotides on the basis that by combining the desirable
properties of both structures we may produce a superior
anti-sense effector. In particular, by extending the methyl-
phosphonate sequences at each end of the molecule we may
enhance cell uptake of the oligodeoxynucleotide in addition
to protecting the molecule from exonucleases (Miller et al.,
1981). In addition, by reducing the length of the internal
phosphodiester sequence we may reduce the target for
endonucleolytic degradation while retaining the ability of the
molecule to direct ribonuclease-H cleavage of mRNA at the
site of hybridisation (Donis-Keller, 1979), an anti-sense
mechanism of sequence specific protein synthesis inhibition
not exhibited by homogeneous methylphosphonate oligo-
nucleotide analogues (Maher & Dolnick, 1988). We envisage
that by reducing the number of phosphodiester linkages to
the minimum required for ribonuclease-H activity it may be
possible to target a specific site on the mRNA (Shibahara et
al., 1987) and hence inhibit expression of a gene carrying a
single point mutation at that site, e.g. codons 12, 13 or 61 of
ras genes (Shen et al., 1987), without affecting expression of
the normal unmutated gene.
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